Cerezyme Market Report 2026

Cerezyme Market Overview

• The Cerezyme market growth in the historic period has been driven by limited treatment options for gaucher disease, success of enzyme replacement therapies • Market expansion is supported by increasing awareness of lysosomal storage disorders, expansion of reimbursement coverage • Growth Driver: Impact Of Rising Research And Development Investment On The Growth Of The Cerezyme Market • Market Trend: Expansion Of Manufacturing Facilities To Meet Growing Demand In The Cerezyme Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cerezyme Market?

Cerezyme refers to an enzyme replacement therapy specifically designed to treat Gaucher disease, a rare genetic disorder caused by a deficiency of the enzyme glucocerebrosidase. It is used for managing symptoms such as enlargement of the spleen and liver, anemia, low blood platelet counts, and bone complications by replacing the missing or deficient enzyme, helping to reduce accumulated fatty substances in affected organs and tissues. The main types of indications for cerezyme include gaucher’s disease (type 1), gaucher’s disease (type 3), and other lysosomal storage disorders. Gaucher’s Disease Type 1 is the most common form of Gaucher's disease, characterized by the accumulation of fatty substances in organs like the liver, spleen, and bones, leading to symptoms such as organ enlargement, bone pain, and anemia. It is distributed through various channels such as direct sales, pharmaceutical wholesalers, online pharmacies and retail pharmacies and used by several end users including hospitals, clinics, ambulatory care, and home care.

What Is The Cerezyme Market Growth Forecast?

The growth in the forecast period can be attributed to increasing awareness of lysosomal storage disorders, expansion of reimbursement coverage, advancements in biologic manufacturing, growth of home care infusion models, sustained orphan drug incentives. Major trends in the forecast period include continued reliance on enzyme replacement therapies, growing diagnosis rates of rare genetic disorders, shift toward long term disease management solutions, expansion of home based infusion therapies, focus on treatment accessibility for rare diseases.

Global Cerezyme Market Segmentation

1) By Indication: Gaucher’s Disease (Type 1), Gaucher’s Disease (Type 3), Other Lysosomal Storage Disorders 2) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Online Pharmacies, Retail Pharmacies 3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

What Are The Drivers Of The Cerezyme Market?

The rising investment in research and development is anticipated to drive the growth of the cerezyme market going forward. Research and development (R&D) is the process of exploring, innovating, and creating new products, services, or technologies through systematic investigation and experimentation to improve or advance existing solutions. Research and development are rising due to increasing demand for innovation, technological advancements, and the need to address complex global challenges in various industries. Investment in research and development helps Cerezyme by driving innovations in enzyme replacement therapies, improving treatment efficacy, enhancing patient outcomes, and expanding its applications to address unmet needs in managing Gaucher disease effectively. For instance, in January 2025, according to the G‑FINDER 2024 report, global funding for hepatitis C researc rose by USD 5.0 million (30%) to USD 21 million in 2023 compared to 2022. Therefore, the rising investment in research and development is driving the growth of the cerezyme industry. Rising healthcare infrastructure facilities are expected to propel the growth of the cerezyme market going forward. Healthcare infrastructure facilities refer to the physical structures, resources, and systems necessary to provide medical services and support the functioning of healthcare systems. Healthcare infrastructure facilities are increasing due to population growth, aging demographics, rising healthcare needs, technological advancements, and greater government and private sector investment. Healthcare infrastructure facilities help cerezyme by providing the necessary resources and advanced medical settings to administer this enzyme replacement therapy effectively. For instance, in April 2025, according to the American Medical Association (AMA), a US-based professional association, U.S. health spending surged by 7.5% in 2023 to reach $4.9 trillion, averaging roughly $14,570 per person, a notable jump from the 4.6% growth rate seen in 2022. Therefore, the rising healthcare infrastructure facilities are driving the growth of the cerezyme industry.

Key Players In The Global Cerezyme Market

Major companies operating in the cerezyme market are Sanofi S.A.

Global Cerezyme Market Trends and Insights

The key trend in the cerezyme market is focusing on expanding its manufacturing facility to increase production capacity, improve efficiency, and meet growing global demand. A biologics manufacturing facility is a specialized plant that uses advanced technologies to produce high-quality biologic drugs like enzymes and antibodies, ensuring scalable production and regulatory compliance. For instance, in November 2024, Sanofi SA, a France-based pharmaceutical company, opened its modular vaccine and biologics manufacturing facility in Singapore for $586 million (€558m). Located in Tuas Biomedical Park, the Modulas site is a state-of-the-art facility designed by Sanofi to produce next-generation vaccines and biologic-based therapeutics simultaneously. Capable of manufacturing up to four vaccines or biopharmaceuticals in parallel, the facility features 34 interconnected standardized production modules that can be rapidly reconfigured to meet specific production needs. This advanced design aims to bolster Sanofi's readiness for future surges in biopharmaceutical demand, including during potential pandemics.

Regional Insights

North America was the largest region in the cerezyme market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Cerezyme Market?

The cerezyme market consists of sales of specialized infusion equipment, gene therapy products, supportive care medications and nutritional supplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cerezyme Market Report 2026?

The cerezyme market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cerezyme industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.